Table 2.
Relationship between DHEAS and frailty and frailty with other study predictors
| Frailty categories (count/%) | ||||||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3–5 | Total | P-value | |
| Non-frail | Intermediate | Intermediate | Frail | |||
| (a) Frailty categories versus DHEAS quartiles | ||||||
| DHEAS quartiles (μg/dL) | <0.0001 | |||||
| 15.0–27.3 | 56/25% | 109/49% | 40/18% | 19/9% | 224/100% | |
| 27.4–46.3 | 64/28% | 108/48% | 41/18% | 12/5% | 225/100% | |
| 46.4–78.1 | 87/39% | 96/43% | 31/14% | 12/5% | 226/100% | |
| 78.3–323.0 | 106/48% | 86/39% | 23/10% | 8/3% | 223/100% | |
| (b) Frailty categories versus other study predictors | ||||||
| Study predictors | <0.0001 | |||||
| ALF | 5/5.1% | 30/30.6% | 40/40.8% | 23/23.5% | 98/100.0% | |
| DHEAEX | 78/33.1% | 125/53.0% | 25/10.6% | 8/3.4% | 236/100.0% | |
| TEST | 230/40.8% | 244/43.3% | 70/12.4% | 20/3.5% | 564/100.0% | |
| Gender | 0.0005 | |||||
| Females | 233/39.4% | 251/42.5% | 79/13.4% | 28/9.1% | 307/100.0% | |
| Males | 80/26.1% | 148/48.2% | 56/18.2% | 23/3.9% | 591/100.0% | |
| Age (years) | <0.0001 | |||||
| 60–69 | 137/55.9% | 82/33.5% | 18/7.3% | 8/3.3% | 245/100.0% | |
| 70–79 | 143/36.4% | 193/49.1% | 44/11.2% | 13/3.3% | 393/100.0% | |
| 80+ | 33/12.7% | 124/47.7% | 73/28.1% | 30/11.5% | 260/100.0% | |
| BMI (kg/m2) | 0.32 | |||||
| <25 | 106/35.5% | 130/43.5% | 46/15.4% | 17/5.7% | 299/100.0% | |
| 25–30 | 154/37.7% | 170/41.7% | 60/14.7% | 24/5.9% | 408/100.0% | |
| 30+ | 53/27.7% | 99/51.8% | 29/15.2% | 10/5.2% | 191/100.0% | |